Kamano Shuji, Matsuyama Masayuki, Minamimura Kenzo
Department of Neurosurgery, Inagi Municipal Hospital, Inagi, Tokyo, Japan.
Department of Neurosurgery, Shinkawabashi Hospital, Kawasaki, Kanagawa, Japan.
NMC Case Rep J. 2020 Sep 14;7(4):211-215. doi: 10.2176/nmccrj.cr.2019-0228. eCollection 2020 Sep.
A 39-year-old man had received boron neutron capture therapy (BNCT) for a grade II astrocytoma (compatible with diffuse astrocytoma, not otherwise specified in the WHO 2016 criteria). He returned to his previous work after surgery, but, 7 years later, he suddenly developed seizures, and his health condition deteriorated. Therefore, he underwent a second surgery. The mass removed in the second operation was mostly necrotic as a result of previous radiation treatment. He then showed no signs of recurrence and did not require any treatment other than antiepileptic drugs for 25 years. He was able to be employed by a listed company until the age of 65 years for light jobs as a physically handicapped individual. This case suggests the effectiveness of BNCT even for rather low-grade astrocytomas.
一名39岁男性因II级星形细胞瘤(符合弥漫性星形细胞瘤,世界卫生组织2016年标准中未另行规定)接受了硼中子俘获疗法(BNCT)。术后他恢复了之前的工作,但7年后,他突然出现癫痫发作,健康状况恶化。因此,他接受了第二次手术。第二次手术切除的肿块由于先前的放射治疗大部分已坏死。此后,他没有复发迹象,25年来除了抗癫痫药物外无需任何治疗。作为身体有残疾的人,他能够在一家上市公司工作到65岁从事轻松的工作。这个病例表明BNCT即使对相当低级别星形细胞瘤也有效。